Back

AF patients with ACS: recent insights from AUGUSTUS and other trials.

18 March 2019 (13:10 - 13:35)
Organised by:
Congress Presentation Part of: Optimizing stroke prevention with NOACs: focus on Atrial Fibrillation (AF) patients with concomitant Acute Coronary Syndrome (ACS) Stroke Prevention EHRA Premium Access EHRA 2019

About the speaker

Photo
Professor Renato Lopes

Duke University Medical Center, Durham (United States of America)

3 More presentations in this session

Presentation thumbnail
NOACs for stroke prevention: achievements to date and impact on AF patient outcomes.
Professor S. Hohnloser (Frankfurt, DE)
Presentation thumbnail
AF patients with ACS: the evolving landscape.
Professor R. Storey (Sheffield, GB)
Presentation thumbnail
Panel discussion / Q&A - Optimizing stroke prevention with NOACs: focus on Atrial Fibrillation (AF) patients with concomitant Acute Coronary Syndrome (ACS).
Professor S. Hohnloser (Frankfurt, DE)

Access the full session

Session thumbnail
Optimizing stroke prevention with NOACs: focus on Atrial Fibrillation (AF) patients with concomitant Acute Coronary Syndrome (ACS)

The Event

Event poster

EHRA 2019

18 March 2019 13:10 CET
You may be interested in
thumbnail
Congress Presentation
Choice of P2Y12 inhibitor and clinical outcomes in the AUGUSTUS study: support for an individualised approach
30 August 2020
thumbnail
ESC TV Today
Episode 10: Non-bacterial thrombotic endocarditis - Managing cardiovascular risk in transgender people
27 February 2025
thumbnail
Congress Presentation
The current impact of atrial fibrillation on prognosis in patients with acute coronary syndrome
15 March 2025
thumbnail
Congress Session
Focus on: antithrombotic regimens for atrial fibrillation patients following catheter-based cardiovascular interventions
28 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources